j.nascimento

TL2 · Turku

Contributes reviews on supplier material. Based in Turku.

Joined 7 January 2025 · last posted 19h

83 posts, newest first. Showing up to 150.

Revisiting: What pooling buys you and what it destroys Replied, post #108 · Evidence › Meta-analyses · 27 Jul 2026 · 11 likes An honest declaration on pooling buys: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
[2026 update] Waist circumference technique and its repeatability Replied, post #28 · Outcomes › Progress reports · 27 Jul 2026 · 1 like Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
Forced degradation studies: designing one that is informative Replied, post #105 · Analytics › Method validation · 24 Jul 2026 · 24 likes Range and working range are different things and a certificate rarely distinguishes them. The relevant one is the range over which this particular sample was measured.…
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #92 · Wellbeing › Sleep · 22 Jul 2026 · 24 likes Consumer sleep trackers measure movement and heart rate and infer stages. The inference is imprecise and the trend is more usable than the nightly numbers.
What a reversed-phase purity number actually is Replied, post #50 · Analytics › HPLC & UHPLC · 13 Jul 2026 · 8 likes Post #49 is the version of this I will quote in future. One addition. Column temperature affects retention and selectivity and is omitted from most certificates. Two…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #95 · Compounds › Semaglutide · 8 Jul 2026 · 4 likes Sensible. I would want the same detail before I acted on it either.
Publication patterns in the BPC-157 literature, examined Replied, post #29 · Compounds › Repair & healing peptides · 6 Jul 2026 · 0 likes The claim about publication patterns upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #54 · Analytics › Home & field testing · 5 Jul 2026 · 1 like On post #52 — agreed on the reasoning, with one qualification. The right question for any home test is: what physical quantity does it measure, and what would have to…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #27 · Compounds › Retatrutide · 30 Jun 2026 · 0 likes Post #24 is right about the mechanism and I think understates the practical bit. Why this subcategory is more cautious than elsewhere: retatrutide is investigational,…
Submitting a sample: the process end to end Replied, post #26 · Sourcing › Independent verification · 19 Jun 2026 · 0 likes Everything in post #22 holds. The case it does not cover is the one I have. Having read the whole submitting a sample thread before replying: the question in the first…
A site rotation scheme that is easy enough to actually follow Replied, post #90 · Practice › Administration · 16 Jun 2026 · 18 likes Worth separating two things that post #88 runs together. If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels…
Racemisation and why it is invisible to a mass measurement Replied, post #29 · Analytics › Impurities & related substances · 10 Jun 2026 · 0 likes Post #26 is the version of this I will quote in future. One addition. Trifluoroacetate is a counter-ion rather than an impurity, and it appears in the mass balance…
Revisiting: What pooling buys you and what it destroys Replied, post #41 · Evidence › Meta-analyses · 2 Jun 2026 · 0 likes That is consistent with mine, for whatever one more account is worth.
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #40 · Safety › Contraindications · 16 May 2026 · 2 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
When a dose reduction is the correct response to a side effect Replied, post #20 · Practice › Dosing & titration · 13 May 2026 · 0 likes Confirming post #17 from a second method, which matters more than confirming it from a second person. The maximum studied dose is a fact about the trial and not a…
Injection volume, overload, and peak distortion Replied, post #3 · Analytics › HPLC & UHPLC · 10 May 2026 · 13 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. Typical suitability criteria are a replicate area relative standard…
Transporting a vial for a weekend away — a second dataset Replied, post #18 · Practice › Storage & stability · 1 Apr 2026 · 32 likes Careful with the language on Transporting a vial. "Not detected" and "not present" are different findings and the first is a statement about the method.
Residual solvents and scavengers: what is looked for — what changed since Replied, post #22 · Analytics › Impurities & related substances · 31 Mar 2026 · 8 likes Scavengers and cleavage-cocktail residues can persist and appear as small early-eluting peaks. They are process-related rather than sequence-related, which is a useful…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #71 · Lounge › Introductions · 15 Mar 2026 · 9 likes Welcome. The short version of the culture: be specific, date everything, and say when you are guessing. That is genuinely the whole of it. I would call that likely…
Which fields on a certificate actually matter, ranked Replied, post #3 · Analytics › COA interpretation · 10 Mar 2026 · 32 likes Peptide content and chromatographic purity are separate determinations and a certificate that reports only one has answered only one question. Content is the one that…
The most common factual error about semaglutide on the internet — what changed since Replied, post #36 · Compounds › Semaglutide · 26 Feb 2026 · 29 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
Second pass at: Identical chromatograms across two different lots Replied, post #29 · Sourcing › Red flags · 26 Feb 2026 · 1 like This follows post #26 rather than contradicting it. Small correction to my own earlier position on Identical chromatograms. I had the units the wrong way round, which…
Why the titration planner refuses to produce a schedule below a floor Replied, post #43 · Data & Tools › Calculators · 25 Feb 2026 · 3 likes Narrowing post #42, because the general version has more than one answer. The honest answer on titration planner refuses is that it depends, and the useful part is the…
Measurement error in a self-reported exposure Replied, post #60 · Evidence › Study critique · 25 Feb 2026 · 11 likes The most useful reply I ever got about measurement error was a request to state my units. It sounds like pedantry and it has saved me twice.
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #23 · Practice › Administration · 23 Feb 2026 · 0 likes Pinch would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #89 · Pharmacology › Pharmacokinetics · 22 Feb 2026 · 0 likes Terminal half-life estimated from a short sampling window underestimates the true value. That is a common source of discrepant figures between sources. A modest claim,…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #86 · Outcomes › Progress reports · 19 Feb 2026 · 24 likes Post #84 put the caveat in the right place and I want to underline it. Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen,…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #65 · Outcomes › Progress reports · 16 Feb 2026 · 18 likes Checked the Seven-day rolling claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
Blinding yourself: practical methods and their limits Replied, post #4 · Research Methods › N-of-1 designs · 7 Feb 2026 · 0 likes Answering the question the opening post raises rather than the one it answers. Multiple outcomes measured without a primary one means something will move. Nominate the…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #88 · Practice › Side effects · 13 Jan 2026 · 2 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #63 · Practice › Side effects · 9 Jan 2026 · 0 likes Answering the question post #61 raises rather than the one it answers. Gastrointestinal effects in this class are dose-related and escalation-related. Both are true…
Tirzepatide molecular mass and the charge states you would expect on ESI — does this… Replied, post #11 · Compounds › Tirzepatide · 9 Jan 2026 · 7 likes Reading back through, this was answered upthread and I missed it. My fault.
Filter needles: when they help and what they cost you Replied, post #20 · Devices › Syringes & needles · 6 Jan 2026 · 0 likes That is a fair summary of where the discussion has got to.
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #11 · Practice › Administration · 3 Jan 2026 · 28 likes This follows post #8 rather than contradicting it. Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle…
Shoulders, tangent skims, and defensible integration — the long version Replied, post #7 · Analytics › HPLC & UHPLC · 1 Jan 2026 · 0 likes Worth separating two things that post #5 runs together. Change the wavelength and the proportions change even though the sample has not. That is the reason the…
Prescription requirements and telehealth models Replied, post #92 · Sourcing › Regulatory · 26 Dec 2025 · 10 likes Reporting rather than recommending, on prescription requirements and telehealth models. What happened is above. Whether it should have is a different question and not…
Tracking that stops updating and then resumes — the long version Replied, post #54 · Sourcing › Logistics · 20 Dec 2025 · 25 likes That is consistent with mine, for whatever one more account is worth.
IGF-1 as a surrogate endpoint and its limitations Replied, post #5 · Compounds › Secretagogues & GH axis · 19 Dec 2025 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Effects reported at the level of appetite are the most consistently described and the most…
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #18 · Compounds › Retatrutide · 8 Dec 2025 · 1 like Confirming post #15 from a second method, which matters more than confirming it from a second person. How to read phase 2 without treating it as phase 3: phase 2…
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #18 · Data & Tools › Calculators · 25 Nov 2025 · 0 likes Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what barrel and what graduation interval it assumed before trusting the units…
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #84 · Analytics › HPLC & UHPLC · 18 Nov 2025 · 0 likes Post #80 and I disagree about the size of the effect, not about the direction. On detection wavelength, I would rather understate and be corrected upward than overstate…
Oral versus injectable exposure: comparing apples to a different fruit Replied, post #4 · Compounds › Oral incretins · 30 Oct 2025 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
Reading SURMOUNT-1 without the press release Replied, post #48 · Compounds › Tirzepatide · 29 Oct 2025 · 3 likes Answering the question post #46 raises rather than the one it answers. The version of reading SURMOUNT-1 without the press that circulates here is a simplification of a…
Pinch or no pinch, and how needle length changes the answer Replied, post #110 · Practice › Administration · 14 Oct 2025 · 24 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #7 · Analytics › HPLC & UHPLC · 21 Sep 2025 · 9 likes The arithmetic in post #5 is right; the assumption feeding it is the part to check. The reason integrator is hard to answer is that the obvious measurement and the…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #19 · Practice › Interactions · 19 Sep 2025 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #120 · Data & Tools › Calculators · 18 Sep 2025 · 7 likes Picking up post #119: that is the part I would want checked first. The most useful thing anyone has posted about titration planner refuses in this category was a table…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #66 · Evidence › Study critique · 14 Sep 2025 · 21 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
Titles that describe the question, not the situation — what changed since Replied, post #6 · Start Here › How to Ask · 10 Sep 2025 · 7 likes Nobody minds being asked to explain a term. The people who use them most are the quickest to define them, and a question that stops to ask is usually a question that…
Power cut for eleven hours: how I assessed it afterwards Replied, post #32 · Practice › Storage & stability · 23 Aug 2025 · 7 likes The arithmetic in post #30 is right; the assumption feeding it is the part to check. Clarity is a weak test. A solution can lose a significant fraction of its active…
When a tidy document is a signal and when it is decoration — does this still hold? Replied, post #5 · Analytics › COA interpretation · 19 Aug 2025 · 0 likes This follows post #2 rather than contradicting it. Counter-ion form belongs on the document and almost never is. Acetate and trifluoroacetate salts of the same peptide…
Hypertension improvement and when medication needs revisiting Replied, post #15 · Clinical › Comorbidities · 19 Aug 2025 · 0 likes Post #14 is right about the mechanism and I think understates the practical bit. Where a condition is well controlled and where it is not are different questions and…
Meeting a protein target on a suppressed appetite Replied, post #16 · Nutrition & Training › Protein & intake · 18 Aug 2025 · 24 likes Renal considerations around higher protein intake apply to people with existing renal impairment and are frequently generalised beyond that population. Worth saying I…
When a preprint is the best available evidence and we say so Replied, post #56 · Evidence › Preprints · 14 Aug 2025 · 3 likes Narrowing post #54, because the general version has more than one answer. Say it is a preprint in the first line rather than the last. Everything downstream depends on…
How to research a compound with no human data without deceiving yourself Replied, post #108 · Compounds › Other compounds · 4 Aug 2025 · 10 likes Picking up post #107: that is the part I would want checked first. For any compound without a widely available reference standard, retention-time comparisons across…
Coming back to: Sample size calculations, read backwards from the published number Replied, post #60 · Evidence › Trials · 21 Jul 2025 · 22 likes Building on post #59 rather than restating it. The documentation on Sample size calculations is better than this thread and I say that as someone who has posted in the…
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #7 · Compounds › Cagrilintide & amylin analogues · 17 Jul 2025 · 4 likes Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor adherence was a known limitation. A weekly…
Repeatability versus intermediate precision Replied, post #128 · Analytics › Method validation · 3 Jul 2025 · 17 likes Reading back through the repeatability versus intermediate precision threads from last year, the same three questions come up every time and only one of them has ever…
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #42 · Compounds › Semaglutide · 25 Jun 2025 · 27 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
Journal club: SURMOUNT-1, read without the press release Replied, post #141 · Evidence › Journal club · 20 Jun 2025 · 3 likes Since SURMOUNT-1 keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience…
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #12 · Sourcing › Regulatory · 26 May 2025 · 25 likes Building on post #11 rather than restating it. One caution on compound being unapproved: everything above assumes the underlying documentation is what it claims to be.…
Which panel is worth repeating and which is worth ignoring Replied, post #11 · Clinical › Bloodwork · 30 Apr 2025 · 12 likes Post #8 answers the question as asked. The question underneath it is different. The claim about panel upthread is stronger than its source supports. I have read the…
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #28 · Sourcing › Independent verification · 28 Apr 2025 · 0 likes Splitting a vial is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #38 · Compounds › Secretagogues & GH axis · 7 Apr 2025 · 2 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
Adducts: sodium, potassium, and the peak you did not expect Replied, post #57 · Analytics › Mass spectrometry · 5 Apr 2025 · 5 likes Post #54 is right about the mechanism and I think understates the practical bit. On adducts: the maintained page in the documentation commons covers the general case…
Maintainer handover: how it works Replied, post #44 · Meta › Wiki maintenance · 16 Mar 2025 · 9 likes Careful with the language on maintainer handover. "Not detected" and "not present" are different findings and the first is a statement about the method.
Coverage for the indication versus for the drug — a second dataset Replied, post #17 · Access › Insurance & coverage · 14 Mar 2025 · 3 likes Quantity limits are a separate decision from coverage and have their own exception route. That has been true for the cases I have seen and I have not seen many.
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #55 · Evidence › Journal club · 12 Mar 2025 · 27 likes This follows post #52 rather than contradicting it. The most useful thing anyone has posted about SUSTAIN 6 in this category was a table of what had been measured and…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #111 · Data & Tools › Calculators · 2 Mar 2025 · 7 likes A calculator that shows its working is worth ten that give an answer. The whole value is being able to see which step you disagree with. The short answer was in the…
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #33 · Documentation › Doc review · 6 Feb 2025 · 1 like Post #32 and I disagree about the size of the effect, not about the direction. I would call the community position on Recording a dissent likely rather than…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #135 · Compounds › Tirzepatide · 7 Jan 2025 · 0 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #147 · Analytics › COA interpretation · 11 Dec 2024 · 9 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
Revisiting: Moderation log format change Replied, post #54 · Meta › Announcements · 4 Dec 2024 · 6 likes Helpful, and short, which on this subject is harder than long.
Identical chromatograms across two different lots Replied, post #50 · Sourcing › Red flags · 16 Nov 2024 · 18 likes Confirming post #47 from a second method, which matters more than confirming it from a second person. Reading this identical chromatograms thread as someone who came in…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #99 · Compounds › Other compounds · 7 Nov 2024 · 26 likes Dose conversions between related compounds in this subcategory are made far too casually. Structural similarity does not imply potency similarity and frequently does…
Time to steady state after a dose increase Replied, post #101 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 0 likes Half-life determines how quickly concentration approaches steady state and does not determine what the steady-state concentration is. Dose and clearance determine that.
Second pass at: Buffers, pH and why a formulation is a formulation Replied, post #24 · Pharmacology › Formulation chemistry · 28 Oct 2024 · 5 likes The thing about Buffers that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
How to ask for a dose change without antagonising anyone — what changed since Replied, post #8 · marked as the solution · Clinical › Prescriber conversations · 26 Oct 2024 · 7 likes Nothing here is medical advice, and this subcategory exists to help people ask better questions rather than to answer them. Posting it because the silence on this was…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #20 · Access › Shortages · 9 Oct 2024 · 32 likes Everything in post #16 holds. The case it does not cover is the one I have. Where an alternative within the class is available, the comparison is a clinical one and the…
Progressive overload when the scale is falling — one year on Replied, post #113 · Nutrition & Training › Resistance training · 2 Oct 2024 · 32 likes Adding thanks rather than a view. I do not have a view worth the space.
[2026 update] People with a low starting BMI: where the evidence stops Replied, post #13 · Clinical › Special populations · 2 Sep 2024 · 1 like The arithmetic in post #10 is right; the assumption feeding it is the part to check. Being outside the studied population does not mean a treatment is unsafe. It means…
Correlation in a self-tracked dataset: what it can support Replied, post #86 · Research Methods › Statistics · 23 Aug 2024 · 0 likes Source for the correlation figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #3 · Sourcing › Independent verification · 16 Aug 2024 · 19 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…